Track the 株式会社コスモス薬品 share price and the full insider trade history of the company, a listed equity based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社コスモス薬品 has logged 13 public disclosures. Market capitalisation: €507.6bn. The latest transaction was filed on 21 April 2026 (Holding update). Among the most active insiders: JPMorgan Asset Management (Japan) Limited. All data is openly available.
Analysts rate 株式会社コスモス薬品 Buy (bullish), based on 10 analysts. Average price target: JP¥7,571.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
13 of 13 declarations
Cosmos Pharmaceutical Corporation es una empresa japonesa que se especializa en la venta de productos farmacéuticos y para el cuidado de la salud. Opera principalmente en el mercado japonés y se centra en la distribución de medicamentos y productos de bienestar.